{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:57:39Z","timestamp":1769075859854,"version":"3.49.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","award":["ZIAAR041222"],"award-info":[{"award-number":["ZIAAR041222"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,15]]},"abstract":"<jats:p>The direct antitumour effects of mTOR inhibitors against cutaneous squamous cell carcinoma (SCC) have prompted a paradigm shift towards using sirolimus for allograft rejection prophylaxis in patients with high-risk SCC who have had a solid organ transplant (SOT). Patients who have had an SOT are at higher risk for Merkel cell carcinoma (MCC), yet there is little evidence concerning potential antitumour effects of immunosuppressive drugs against MCC. Screening seven immunosuppressive drugs in six MCC cell lines revealed that mycophenolate mofetil (MMF) had strong antitumour activity (surpassing mTOR inhibitors) and higher potency in MCC vs. other cancer types. MMF also inhibited MCC tumour growth in mice. Our preclinical findings strongly suggest the utility of MMF in patients with MCC who require immunosuppression.<\/jats:p>","DOI":"10.1093\/bjd\/ljae018","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T22:17:52Z","timestamp":1706134672000},"page":"593-595","source":"Crossref","is-referenced-by-count":2,"title":["Mycophenolate mofetil inhibits Merkel cell carcinoma growth"],"prefix":"10.1093","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3818-5939","authenticated-orcid":false,"given":"Khalid A","family":"Garman","sequence":"first","affiliation":[{"name":"Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH) , Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Thoreson","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine , Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4453-3234","authenticated-orcid":false,"given":"Jennifer","family":"Strong","sequence":"additional","affiliation":[{"name":"Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH) , Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1998-1119","authenticated-orcid":false,"given":"Patrick","family":"Hallaert","sequence":"additional","affiliation":[{"name":"Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH) , Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Gelb","sequence":"additional","affiliation":[{"name":"Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH) , Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8218-0433","authenticated-orcid":false,"given":"Min","family":"Shen","sequence":"additional","affiliation":[{"name":"Division of Pre-clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) , Bethesda, MD , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D","family":"Hall","sequence":"additional","affiliation":[{"name":"Division of Pre-clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) , Bethesda, MD , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-9914","authenticated-orcid":false,"given":"Isaac","family":"Brownell","sequence":"additional","affiliation":[{"name":"Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and National Cancer Institute (NCI), National Institutes of Health (NIH) , Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"2024031513095344200_ljae018-B1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41571-018-0103-2","article-title":"The biology and treatment of Merkel cell carcinoma: current understanding and research priorities","volume":"15","author":"Harms","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2024031513095344200_ljae018-B2","doi-asserted-by":"crossref","first-page":"dju382","DOI":"10.1093\/jnci\/dju382","article-title":"Risk of merkel cell carcinoma after solid organ transplantation","volume":"107","author":"Clarke","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2024031513095344200_ljae018-B3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jaad.2014.05.054","article-title":"Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation","volume":"71","author":"Arron","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2024031513095344200_ljae018-B4","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/jdv.18256","article-title":"Clinicopathological features, MCPyV status and outcomes of Merkel cell carcinoma in solid-organ transplant recipients: a retrospective, multicentre cohort study","volume":"36","author":"Ferrandiz-Pulido","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024031513095344200_ljae018-B5","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gfn605","article-title":"Immunosuppressive therapy and post-transplant malignancy","volume":"24","author":"Domhan","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2024031513095344200_ljae018-B6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","article-title":"Recent advances and limitations of mTOR inhibitors in the treatment of cancer","volume":"22","author":"Ali","year":"2022","journal-title":"Cancer Cell Int"},{"key":"2024031513095344200_ljae018-B7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat Cancer"},{"key":"2024031513095344200_ljae018-B8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/jid.2014.518","article-title":"Assessment of cancer cell line representativeness using microarrays for Merkel cell carcinoma","volume":"135","author":"Daily","year":"2015","journal-title":"J Invest Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae018\/56707475\/ljae018.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/190\/4\/593\/56986109\/ljae018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/190\/4\/593\/56986109\/ljae018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T13:10:19Z","timestamp":1710508219000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/190\/4\/593\/7588419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":8,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,1,24]]},"published-print":{"date-parts":[[2024,3,15]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae018","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,1,24]]}}}